IRVINE, Calif., Jan. 18, 2007 (PRIME NEWSWIRE) -- "For an extended period of time, stem cell equities have busily conducted research under the black cloud of funding limitations," stated SmallCap Sentinel analyst D.R. Clark. "Now, with the political landscape having changed so dramatically, stem cell equities are finding a more welcoming and perhaps brighter path."
"Case in point, Advanced Cell Technology, Inc. (OTCBB:ACTC) was awarded a research grant from the National Institutes of Health (NIH) in the amount of $204,439 in conjunction with a research project currently underway with one of its academic partners," Clark noted. "I believe this exemplifies a dramatic change in the government's sentiment toward stem cell research while simultaneously enhancing confidence for Advanced Cell's business plan."
"These types of funding events don't happen for every company that applies," Clark added. "This is a defining moment for Advanced Cell Technology."
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts.
For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To view Advanced Cell's Investor Fact Sheet, visit http://www.trilogy-capital.com/tcp/advanced_cell/factsheet.html. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.
An informational report titled "Looking at the Political Impact on Stem Cell Research" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com. The report addresses Advanced Cell Technology, Inc. (OTCBB:ACTC), StemCells Inc. (Nasdaq:STEM), Aastrom Biosciences Inc. (Nasdaq:ASTM), and Geron Corp. (Nasdaq:GERN).
Individuals may also register to receive free future reports at: http://stockupticks.com/register.html
To have your company featured in StockUpTicks or SmallCap Sentinel please contact the editors using the information below.
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
Information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy, nor offer to sell securities, but is rather a paid advertisement provided for information purposes only and shouldn't be used as basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $1,500 by Advanced Cell Technology, Inc. for preparation and distribution of this report and other advertising services. An editor of SmallCap Sentinel currently holds a position in STEM. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding the subject companies.